Biologically Active Small Molecules

A derivative of hydrochlorothiazide, which is a diuretic and antihypertensive agent that increases renal excretion of sodium, potassium, chloride, and bicarbonate ions by inhibiting tubular reabsorptive mechanisms.

A thymidine analog that is readily incorporated, following phosphorylation, into newly synthesized DNA in place of thymidine can be detected immunologically in cells and tissues.

A thymidine analog that is readily incorporated, following phosphorylation, into newly synthesized DNA in place of thymidine can be detected immunologically in cells and tissues.

A thymidine analog that is readily incorporated, following phosphorylation, into newly synthesized DNA in place of thymidine can be detected immunologically in cells and tissues.

5-Chloroesorcinol dimethyl ether is a synthetic intermediate useful for pharmaceutical synthesis.

5-Chloroesorcinol dimethyl ether is a synthetic intermediate useful for pharmaceutical synthesis.

5-Chloroesorcinol dimethyl ether is a synthetic intermediate useful for pharmaceutical synthesis.

5-Chloroesorcinol dimethyl ether is a synthetic intermediate useful for pharmaceutical synthesis.

5-cis Carbaprostacyclin is a stable analog of PGI2 and an isomer of carbaprostacyclin. It is a weak inhibitor of human platelet aggregation with an IC₅₀ of 2.

5-cis Carbaprostacyclin is a stable analog of PGI2 and an isomer of carbaprostacyclin. It is a weak inhibitor of human platelet aggregation with an IC₅₀ of 2.

5-cis Iloprost is the C-5 cis-isomer of iloprost, a second generation structural analog of PGI2 (prostacyclin). Iloprost displays ten-fold greater potency than the first generation stable prostacyclin analogs, typified by carbaprostacyclin.

5-cis Iloprost is the C-5 cis-isomer of iloprost, a second generation structural analog of PGI2 (prostacyclin). Iloprost displays ten-fold greater potency than the first generation stable prostacyclin analogs, typified by carbaprostacyclin.